Infrared imaging technology provider OmniCorder Technologies has delivered its BioScanIR system to Italy's National Tumor Institute in Milan, according to the East Setauket, NY-based vendor.
The specially configured system will be part of an international study to monitor breast cancer patients undergoing neoadjuvant cancer therapy, the company said.
By AuntMinnie.com staff writers
October 15, 2004
Related Reading
OmniCorder finalizes name change, February 27, 2004
OmniCorder gets BioScanIR CE Mark, September 23, 2003
Thermal imaging market for breast cancer heats up, January 27, 2000
Copyright © 2004 AuntMinnie.com